Hope For Advanced Thymic Cancer Patients: New International Study Targets Rare Cancer
Thursday, December 10th, 2009The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug specifically for thymic cancer based on early promising results at Scottsdale Healthcare. PHA-848125ac is produced by Nerviano Medical Sciences of Milan, Italy's largest pharmaceutical research and development facility. It is designed to stop ...